Up-regulation of multidrug resistance protein MDR1/ABCB1 in carfilzomib-resistant multiple myeloma differentially affects efficacy of anti-myeloma drugs

被引：8
|
作者：
Byrgazov, Konstantin [1 ]
Kraus, Marianne [2 ]
Besse, Andrej [2 ]
Slipicevic, Ana [1 ]
Lehmann, Fredrik [1 ]
Driessen, Christoph [2 ]
Besse, Lenka [2 ]
机构：
[1] Oncopeptides AB, Stockholm, Sweden
[2] Cantonal Hosp St Gallen, Expt Oncol & Hematol, Dept Oncol & Hematol, St Gallen, Switzerland
来源：
LEUKEMIA RESEARCH | 2021年 / 101卷
关键词：
Myeloma; Drug resistance; Proteasome inhibitors; MDR1; P-GLYCOPROTEIN; INHIBITOR; OVEREXPRESSION; EXPRESSION; CELLS; MDR1;
D O I：
10.1016/j.leukres.2020.106499
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：5
相关论文
共 13 条
  • [1] Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma
    Jamroziak, Krzysztof
    Balcerczak, Ewa
    Calka, Karolina
    Piaskowski, Sylwester
    Urbanska-Rys, Halina
    Salagacka, Aleksandra
    Mirowski, Marek
    Robak, Tadeusz
    LEUKEMIA RESEARCH, 2009, 33 (02) : 332 - 335
  • [2] Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma
    Besse, A.
    Stolze, S. C.
    Rasche, L.
    Weinhold, N.
    Morgan, G. J.
    Kraus, M.
    Bader, J.
    Overkleeft, H. S.
    Besse, L.
    Driessen, C.
    LEUKEMIA, 2018, 32 (02) : 391 - 401
  • [3] Multidrug resistance 1 (MDR1/ABCB1) gene polymorphism (rs1045642 C > T) and susceptibility to multiple myeloma: a systematic review and meta-analysis
    Razi, Bahman
    Sarab, Gholamreza Anani
    Omidkhoda, Azadeh
    Alizadeh, Shahab
    HEMATOLOGY, 2018, 23 (08) : 456 - 462
  • [4] Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells
    Tsubaki, Masanobu
    Satou, Takao
    Itoh, Tatsuki
    Imano, Motohiro
    Komai, Makiko
    Nishinobo, Minori
    Yamashita, Megumi
    Yanae, Masashi
    Yamazoe, Yuzuru
    Nishida, Shozo
    LEUKEMIA RESEARCH, 2012, 36 (10) : 1315 - 1322
  • [5] Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1
    Hawley, Teresa S.
    Riz, Irene
    Yang, Wenjing
    Wakabayashi, Yoshiyuki
    DePalma, Louis
    Chang, Young-Tae
    Peng, Weiqun
    Zhu, Jun
    Hawley, Robert G.
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (04) : 265 - 272
  • [6] The Relationship of ABCB1/MDR1 and CYP1A1 Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma
    Zmorzynski, Szymon
    Wojcierowska-Litwin, Magdalena
    Popek-Marciniec, Sylwia
    Szudy-Szczyrek, Aneta
    Styk, Wojciech
    Chocholska, Sylwia
    Filip, Agata Anna
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [7] Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability
    Wang, DX
    Johnson, AD
    Papp, AC
    Kroetz, DL
    Sadée, W
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (10) : 693 - 704
  • [8] Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma
    Schwarzenbach, H
    MEDICAL ONCOLOGY, 2002, 19 (02) : 87 - 104
  • [9] Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma
    Heidi Schwarzenbach
    Medical Oncology, 2002, 19 : 87 - 104
  • [10] RAPID UP-REGULATION OF MDR1 EXPRESSION BY ANTHRACYCLINES IN A CLASSICAL MULTIDRUG-RESISTANT CELL-LINE
    HU, XF
    SLATER, A
    WALL, DM
    KANTHARIDIS, P
    PARKIN, JD
    COWMAN, A
    ZALCBERG, JR
    BRITISH JOURNAL OF CANCER, 1995, 71 (05) : 931 - 936
12